New Challenges for In-House Pharmacies

New Challenges for In-House Pharmacies

May 14, 2020

Many oncology medications fall under the umbrella of specialty pharmacy medications. Over the past few years, an increasing number of oncology prescriber offices have added in-house specialty pharmacies to meet their patients’ needs for specialty medications. This new model of in-house specialty pharmacy offers several benefits for patients, such as the ability to pick up their medications at the point of care while they are at the prescriber’s office for regular appointments.

However, the Covid-19 crisis is changing the way many things work in the medical field, especially for oncology patients who are among the more likely to be immunocompromised. Some oncology offices continue to have limitations for in-person appointments and some patients continue to be more comfortable with remote/telemedicine appointments (when possible) to limit any potential exposure during times of immunocompromised health. All this has added an extra hurdle to the delivery system of specialty medications.

Does This Sound Like Your In-House Pharmacy?

Staffing changes, new roles for your staff, and remote appointments might be creating difficulties related to benefits investigation, prior authorizations, financial assistance, refills, and navigation of adverse effects for you and your patients.

With these current Covid-19 challenges in mind, please know that BioPlus Specialty Pharmacy is available to partner with your office to meet the specialty pharmacy needs of your patients.

Consider outsourcing to BioPlus to get your patients the prescriptions they need: it’s fast and easy and delivered next day to their doorstep. And when your in-house pharmacy is ready again, we’ll easily transfer patients back to your care!

Remember, you can count on BioPlus in these tough times, and in the better days ahead.

Share this article

Share on facebook
Share on twitter
Share on linkedin
Share on email
Scroll to Top